Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12

Michael Crump; John Kuruvilla; Stephen Couban; David A. MacDonald; Vishal Kukreti; C. Tom Kouroukis; Morel Rubinger; Rena Buckstein; Kevin R. Imrie; Massimo Federico; Nicola Di Renzo; Kang Howson-Jan; Tara Baetz; Leonard Kaizer; Michael Voralia; Harold J. Olney; A. Robert Turner; Jonathan Sussman; Annette E. Hay; Marina S. Djurfeldt; Ralph M. Meyer; Bingshu E. Chen; Lois E. Shepherd

doi:10.1200/JCO.2013.53.9593

Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12

Michael Crump, John Kuruvilla, Stephen Couban, David A. MacDonald, Vishal Kukreti, C. Tom Kouroukis, Morel Rubinger, Rena Buckstein, Kevin R. Imrie, Massimo Federico, Nicola Di Renzo, Kang Howson-Jan, Tara Baetz, Leonard Kaizer, Michael Voralia, Harold J. Olney, A. Robert Turner, Jonathan Sussman, Annette E. Hay, Marina S. DjurfeldtRalph M. Meyer, Bingshu E. Chen, Lois E. Shepherd

Pharmacology, Toxicology and Pharmaceutics

Research output: Contribution to journal › Article › peer-review

358 Citations (Scopus)

Original language	English
Pages (from-to)	3490-3496
Number of pages	7
Journal	Journal of Clinical Oncology
Volume	32
Issue number	31
DOIs	https://doi.org/10.1200/JCO.2013.53.9593
Publication status	Published - Nov 1 2014

ASJC Scopus Subject Areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.2013.53.9593

Fingerprint

Dive into the research topics of 'Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12'. Together they form a unique fingerprint.

Cite this

Crump, M., Kuruvilla, J., Couban, S., MacDonald, D. A., Kukreti, V., Kouroukis, C. T., Rubinger, M., Buckstein, R., Imrie, K. R., Federico, M., Di Renzo, N., Howson-Jan, K., Baetz, T., Kaizer, L., Voralia, M., Olney, H. J., Turner, A. R., Sussman, J., Hay, A. E., ... Shepherd, L. E. (2014). Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12. Journal of Clinical Oncology, 32(31), 3490-3496. https://doi.org/10.1200/JCO.2013.53.9593

Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12. / Crump, Michael; Kuruvilla, John; Couban, Stephen et al.
In: Journal of Clinical Oncology, Vol. 32, No. 31, 01.11.2014, p. 3490-3496.

Research output: Contribution to journal › Article › peer-review

Crump, M, Kuruvilla, J, Couban, S, MacDonald, DA, Kukreti, V, Kouroukis, CT, Rubinger, M, Buckstein, R, Imrie, KR, Federico, M, Di Renzo, N, Howson-Jan, K, Baetz, T, Kaizer, L, Voralia, M, Olney, HJ, Turner, AR, Sussman, J, Hay, AE, Djurfeldt, MS, Meyer, RM, Chen, BE & Shepherd, LE 2014, 'Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12', Journal of Clinical Oncology, vol. 32, no. 31, pp. 3490-3496. https://doi.org/10.1200/JCO.2013.53.9593

Crump M, Kuruvilla J, Couban S, MacDonald DA, Kukreti V, Kouroukis CT et al. Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12. Journal of Clinical Oncology. 2014 Nov 1;32(31):3490-3496. doi: 10.1200/JCO.2013.53.9593

Crump, Michael ; Kuruvilla, John ; Couban, Stephen et al. / Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas : NCIC-CTG LY.12. In: Journal of Clinical Oncology. 2014 ; Vol. 32, No. 31. pp. 3490-3496.

@article{17e6450e9b5c40ee9aa381cc1c4c8502,

title = "Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12",

author = "Michael Crump and John Kuruvilla and Stephen Couban and MacDonald, {David A.} and Vishal Kukreti and Kouroukis, {C. Tom} and Morel Rubinger and Rena Buckstein and Imrie, {Kevin R.} and Massimo Federico and {Di Renzo}, Nicola and Kang Howson-Jan and Tara Baetz and Leonard Kaizer and Michael Voralia and Olney, {Harold J.} and Turner, {A. Robert} and Jonathan Sussman and Hay, {Annette E.} and Djurfeldt, {Marina S.} and Meyer, {Ralph M.} and Chen, {Bingshu E.} and Shepherd, {Lois E.}",

note = "Publisher Copyright: {\textcopyright} 2014 by American Society of Clinical Oncology.",

year = "2014",

month = nov,

day = "1",

doi = "10.1200/JCO.2013.53.9593",

language = "English",

volume = "32",

pages = "3490--3496",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "31",

}

TY - JOUR

T1 - Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas

T2 - NCIC-CTG LY.12

AU - Crump, Michael

AU - Kuruvilla, John

AU - Couban, Stephen

AU - MacDonald, David A.

AU - Kukreti, Vishal

AU - Kouroukis, C. Tom

AU - Rubinger, Morel

AU - Buckstein, Rena

AU - Imrie, Kevin R.

AU - Federico, Massimo

AU - Di Renzo, Nicola

AU - Howson-Jan, Kang

AU - Baetz, Tara

AU - Kaizer, Leonard

AU - Voralia, Michael

AU - Olney, Harold J.

AU - Turner, A. Robert

AU - Sussman, Jonathan

AU - Hay, Annette E.

AU - Djurfeldt, Marina S.

AU - Meyer, Ralph M.

AU - Chen, Bingshu E.

AU - Shepherd, Lois E.

PY - 2014/11/1

Y1 - 2014/11/1

UR - http://www.scopus.com/inward/record.url?scp=84911498561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84911498561&partnerID=8YFLogxK

U2 - 10.1200/JCO.2013.53.9593

DO - 10.1200/JCO.2013.53.9593

M3 - Article

C2 - 25267740

AN - SCOPUS:84911498561

SN - 0732-183X

VL - 32

SP - 3490

EP - 3496

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 31

ER -

Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this